Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Cash-and-Equivalents" stands at 8.91 Billion Euros as of 09/30/2025.
As of the end of Sanofi SA's third quarter, the item "Cash and Equivalents" stands at 8.91 Billion EUR. This represents a decrease of -42.01 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.11 Billion Euros compared to the value the year prior.
The 1 year change is 2.11 Billion Euros.
The 3 year change is 15.80 Billion Euros.
The 5 year change is 24.88 Billion Euros.
The 10 year change is 13.83 Billion Euros.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Equivalents | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash and Equivalents | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash and Equivalents | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Equivalents | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash and Equivalents | 280,205,508,085.11 |